Articles by Control, a senior compliance officer - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Control, a senior compliance officer

Out of Date, Out of Touch

Look ahead to keep from falling behind.
Jun 2, 2007

Look ahead to keep from falling behind.

Falling to Pieces

Breaking up is easy to do.
May 2, 2007

Breaking up is easy to do.

Labeled a Disaster

Mishaps in packaging labels serve as a reminder: the recall is in the details.
Apr 2, 2007

Mishaps in packaging labels serve as a reminder: the recall is in the details.

Maintain Your Moving Parts

Just because the wheels are turning doesn't mean they're going forward.
Mar 2, 2007

Just because the wheels are turning doesn't mean they're going forward.

Packaging Predicaments

Cautionary Tales from the Files of "Control"
Feb 2, 2007

It's what's on the outside that counts, too.

Eventful Adversities

The road to compliance is sometimes littered with lost letters, hot lots, and unmixed mix-ups.
Jan 2, 2007

The production staff was sure the lab couldn't test their way out of a paper bag.

Adventures in Chromatography

Mistakes happen even in the best chromatography laboratories.
Dec 2, 2006

We really knew what we were doing—until we opened the column for a routine repacking.

Getting Personal

Cautionary tales from the files of "Control"
Nov 2, 2006

Here's to all the difficult, out-of-touch, and irresponsible coworkers that make our workplace interesting.

Accidents by Flood and Field

Cautionary notes from the files of "Control"
Oct 2, 2006

Getting "swamped at work" takes on an entirely new meaning for these GMP Agents.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here